Full Press Release Details
Ocuphire Pharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4).
IRD
Ocuphire Pharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Key Takeaway: Ocuphire Pharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)